New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 21, 2014
10:20 EDTKRE, AMPE, TER, CSOD, JRJC, CDNS, PLCE, IRFHigh option volume stocks
High option volume stocks: TER IRF JRJC AMPE PLCE XEO SYF CSOD KRE CDNS
News For TER;IRF;JRJC;AMPE;PLCE;CSOD;KRE;CDNS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 21, 2015
09:14 EDTAMPEAmpio to host business news update conference call
Subscribe for More Information
April 20, 2015
08:49 EDTAMPEAmpio announces STRIDE study AP008 did not reach its primary endpoint
Ampio Pharmaceuticals announced that the multiple injection STRIDE study AP008 did not reach its primary endpoint against the saline control even though there was a statistically significant reduction in pain compared to baseline for patients receiving Ampion. This pain reduction with Ampion was consistent across all sites and with our previously reported studies Ampion is safe and well tolerated. Ampio Pharmaceuticals launched the Phase III program for AmpionTM to treat pain due to osteoarthritis, OA, of the knee. Each patient received three 4ml intra-articular injections of Ampion, or the saline placebo, one at baseline, the second at two weeks and the third at four weeks. In OA, saline is known to be a partial therapeutic and not a true placebo, but has been the control used in all published OA drug trials.
April 13, 2015
08:05 EDTPLCEChildren's Place rejects director nominations from Barington, Macellum
The Children's Place confirmed that it has received notice from Barington Capital Group, L.P. and Macellum Advisors GP, LLC, which collectively own less than 2% of the company’s shares, that they have nominated three individuals in opposition to The Children’s Place’s three nominees -- Norman Matthews, Kenneth Reiss and Stanley Reynolds -- standing for re-election to the Board of Directors at the company’s 2015 Annual Meeting of Stockholders, to be held on May 22, 2015. The Children’s Place's Board of Directors has evaluated Barington and Macellum’s nominees and concluded that the company’s three nominees and the other members of the Board have the right combination of expertise, experience and independence. As such, the Board recommends election of the company’s nominees and has rejected the Barington/Macellum nominees. Stockholders do not need to take any action at this time. Matthews continued: “We appreciate constructive input from our shareholders and are always open to listen to ideas to improve the Company. However, we believe that Barington and Macellum’s views on the Company’s leadership and performance are simply incorrect. Our Board and management team are driving a transformation of The Children’s Place, which has resulted in a significant increase in shareholder value, measured by an increase in stock price, share repurchases and the payment of dividends. Substantial progress has been made, and we expect to continue to see the benefits of our meaningful investments in 2015. Our management team has updated our merchandise assortments, developed and is implementing a sweeping systems and technology transformation plan, transformed our outlet channel, launched international franchise and wholesale businesses, and evaluated and continues to optimize our store fleet. We believe The Children’s Place is well positioned to continue to excel in the intensely competitive specialty children’s apparel category.” Goldman, Sachs & Co. is financial advisor to The Children’s Place. Paul, Weiss, Rifkind, Wharton & Garrison LLP is the Company’s legal advisor.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use